ATE64391T1 - Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel. - Google Patents

Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.

Info

Publication number
ATE64391T1
ATE64391T1 AT89301256T AT89301256T ATE64391T1 AT E64391 T1 ATE64391 T1 AT E64391T1 AT 89301256 T AT89301256 T AT 89301256T AT 89301256 T AT89301256 T AT 89301256T AT E64391 T1 ATE64391 T1 AT E64391T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
group
production
pharmaceutical agent
Prior art date
Application number
AT89301256T
Other languages
English (en)
Inventor
Vittorio Vecchietti
Antonio Giordani
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Application granted granted Critical
Publication of ATE64391T1 publication Critical patent/ATE64391T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT89301256T 1988-02-12 1989-02-09 Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel. ATE64391T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803259A GB8803259D0 (en) 1988-02-12 1988-02-12 Compounds
EP89301256A EP0333315B1 (de) 1988-02-12 1989-02-09 Azacyclische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutisches Mittel

Publications (1)

Publication Number Publication Date
ATE64391T1 true ATE64391T1 (de) 1991-06-15

Family

ID=10631593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301256T ATE64391T1 (de) 1988-02-12 1989-02-09 Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.

Country Status (14)

Country Link
US (1) US4994450A (de)
EP (1) EP0333315B1 (de)
JP (1) JPH01246258A (de)
KR (1) KR890012963A (de)
AT (1) ATE64391T1 (de)
AU (1) AU615984B2 (de)
DE (1) DE68900113D1 (de)
DK (1) DK65489A (de)
ES (1) ES2039845T3 (de)
GB (1) GB8803259D0 (de)
GR (1) GR3002230T3 (de)
NZ (1) NZ227930A (de)
PT (1) PT89677A (de)
ZA (1) ZA891052B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3670080D1 (de) * 1985-12-23 1990-05-10 Zambeletti Spa L Azacyclische verbindungen, verfahren zur ihrer herstellung und ihre verwendung als pharmazeutika.
US5512567A (en) * 1988-08-24 1996-04-30 Sankyo Company, Limited Analgesic compounds, their preparation, and pharmaceutical compositions containing them
EP0361791B1 (de) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclische Verbindungen, verwendbar als Arzneimittel
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
EP0447704A1 (de) * 1990-03-21 1991-09-25 Smithkline Beecham Farmaceutici S.p.A. N-Acylierte azyklische Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
CA2081351A1 (en) * 1990-04-28 1991-10-29 Vittorio Vecchietti 1-(2h-1-oxo-3, 4-dihydronaphtyl-6) -acetyl-piperidines, process for their preparation and therapeutic use
GB9011656D0 (en) * 1990-05-24 1990-07-11 Zambeletti Spa L Novel compounds
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (de) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-Informatiksystem
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN105299030B (zh) * 2015-11-23 2018-03-23 荣腾实业(苏州)有限公司 一种驱动轴导向机构

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052311A1 (de) * 1980-11-19 1982-05-26 Sterling Drug Inc. 1-(Benzoylphenyl-niederalkyl)-piperidine und entsprechende Carbinole und ihre Herstellung
US4656182A (en) * 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
DE3409237A1 (de) * 1984-03-14 1985-09-19 Dr. Karl Thomae Gmbh, 7950 Biberach Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3670080D1 (de) * 1985-12-23 1990-05-10 Zambeletti Spa L Azacyclische verbindungen, verfahren zur ihrer herstellung und ihre verwendung als pharmazeutika.
DE3782191T2 (de) * 1986-06-05 1993-02-25 Ici America Inc Difluorketoverbindungen.
DE3767816D1 (de) * 1986-09-02 1991-03-07 Zambeletti Spa L 1-acylsubstituierte piperidinderivate.
NZ223017A (en) * 1986-12-22 1990-07-26 Zambeletti Spa L Piperidine derivatives and analgesics

Also Published As

Publication number Publication date
DK65489D0 (da) 1989-02-10
GB8803259D0 (en) 1988-03-09
DK65489A (da) 1989-08-13
AU2983489A (en) 1989-08-17
ZA891052B (en) 1991-03-27
US4994450A (en) 1991-02-19
EP0333315A1 (de) 1989-09-20
AU615984B2 (en) 1991-10-17
KR890012963A (ko) 1989-09-20
JPH01246258A (ja) 1989-10-02
DE68900113D1 (de) 1991-07-18
NZ227930A (en) 1992-05-26
GR3002230T3 (en) 1992-12-30
EP0333315B1 (de) 1991-06-12
PT89677A (pt) 1989-10-04
ES2039845T3 (es) 1993-10-01

Similar Documents

Publication Publication Date Title
DE68900113D1 (de) Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.
FR2673179B1 (fr) Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
DE3762618D1 (de) Amidderivate.
NZ236327A (en) Substituted pyrrolidines and piperidines, and use thereof for preparing amino acid derivatives
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
BG101402A (en) Apoliprotein-b synthesis inhibitors
DE69400382D1 (de) Zusammensetzung zur Förderung des Lipidmetabolismus
DE3867403D1 (de) L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung.
ATE242241T1 (de) Imidazopyridinderivate und verfahren zu ihrer herstellung
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69022294D1 (de) N-Heteroaryl-purin-6-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
HUP0000894A2 (hu) Szubsztituált (1,3-bisz(ciklohexilmetil)-1,2,3,6-tetrahidro-2,6-dioxo-9H-purin-8-il)fenil-származékok és eljárás előállításukra
DE60238367D1 (de) Asymmetrischer Kupferkomplex und dessen Verwendung in Cyclopropanierungsreaktion
ATE138067T1 (de) 1,2,4-triazolo(1,5-a>pyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ZA905556B (en) Pharmaceuticals
ATE66672T1 (de) Neue schwefelverbindungen, verfahren zu ihrer herstellung sowie arzneimittel.
SE8303913D0 (sv) Heterocykliska foreningar
EP0856509A3 (de) Verfahren zur Herstellung von Diacylimiden
DE3770117D1 (de) Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE60040653D1 (de) Carbonsäurederivate und verfahren zu ihrer herstellung
DE3862426D1 (de) 2-selenomethyl-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.